Cargando…

Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy

To identify clinicopathologic and treatment variables that could predict pathologic tumor response to short-term neoadjuvant chemotherapy (NAC) for patients with locally advanced gastric cancer. A retrospective analysis was conducted of 178 patients who underwent short-term NAC with EOX regimen foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhen-Feng, Cao, Qin-Hong, Wu, Xiao-Yu, Chen, Che, Xu, Zhe, Li, Wei-Su, Yao, Xue-Quan, Liu, Fu-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664910/
https://www.ncbi.nlm.nih.gov/pubmed/26620627
http://dx.doi.org/10.1038/srep17516
_version_ 1782403510893019136
author Wu, Zhen-Feng
Cao, Qin-Hong
Wu, Xiao-Yu
Chen, Che
Xu, Zhe
Li, Wei-Su
Yao, Xue-Quan
Liu, Fu-Kun
author_facet Wu, Zhen-Feng
Cao, Qin-Hong
Wu, Xiao-Yu
Chen, Che
Xu, Zhe
Li, Wei-Su
Yao, Xue-Quan
Liu, Fu-Kun
author_sort Wu, Zhen-Feng
collection PubMed
description To identify clinicopathologic and treatment variables that could predict pathologic tumor response to short-term neoadjuvant chemotherapy (NAC) for patients with locally advanced gastric cancer. A retrospective analysis was conducted of 178 patients who underwent short-term NAC with EOX regimen followed by surgery from January 2008 to December 2010. Neoadjuvant treatment response was evaluated using tumor regression grade. Relationships between pathologic tumor response and clinicopathological factors were evaluated using logistic regression analysis. The benefits of regional arterial infusion chemotherapy were investigated separately. The postoperative pathological response rate was 46.1% (82/178) and 4 patients (2.2%) had complete pathological remission. Pathological response was significantly associated with tumor differentiation (P = 0.008), abnormal a-fetoprotein levels (P = 0.01) and administration approach to chemotherapy (intravenous versus regional arterial infusion chemotherapy) (P = 0.018). Most bone marrow toxicities, vomiting, nausea, alopecia, and fatigue were acceptable. Grade 3/4 toxicities were not commonly observed. The 3-year overall survival (OS) and recurrence free survival (RFS) were 67.0% and 53.0%, respectively. Regional arterial infusion NAC group had significantly better median RFS (48.0 versus 34.0 months) than the intravenous NAC group (P = 0.049). In conclusion, regional arterial infusion NAC can improve the pathological response rate of advanced gastric cancer treated with EOX regimen.
format Online
Article
Text
id pubmed-4664910
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46649102015-12-03 Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy Wu, Zhen-Feng Cao, Qin-Hong Wu, Xiao-Yu Chen, Che Xu, Zhe Li, Wei-Su Yao, Xue-Quan Liu, Fu-Kun Sci Rep Article To identify clinicopathologic and treatment variables that could predict pathologic tumor response to short-term neoadjuvant chemotherapy (NAC) for patients with locally advanced gastric cancer. A retrospective analysis was conducted of 178 patients who underwent short-term NAC with EOX regimen followed by surgery from January 2008 to December 2010. Neoadjuvant treatment response was evaluated using tumor regression grade. Relationships between pathologic tumor response and clinicopathological factors were evaluated using logistic regression analysis. The benefits of regional arterial infusion chemotherapy were investigated separately. The postoperative pathological response rate was 46.1% (82/178) and 4 patients (2.2%) had complete pathological remission. Pathological response was significantly associated with tumor differentiation (P = 0.008), abnormal a-fetoprotein levels (P = 0.01) and administration approach to chemotherapy (intravenous versus regional arterial infusion chemotherapy) (P = 0.018). Most bone marrow toxicities, vomiting, nausea, alopecia, and fatigue were acceptable. Grade 3/4 toxicities were not commonly observed. The 3-year overall survival (OS) and recurrence free survival (RFS) were 67.0% and 53.0%, respectively. Regional arterial infusion NAC group had significantly better median RFS (48.0 versus 34.0 months) than the intravenous NAC group (P = 0.049). In conclusion, regional arterial infusion NAC can improve the pathological response rate of advanced gastric cancer treated with EOX regimen. Nature Publishing Group 2015-12-01 /pmc/articles/PMC4664910/ /pubmed/26620627 http://dx.doi.org/10.1038/srep17516 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Wu, Zhen-Feng
Cao, Qin-Hong
Wu, Xiao-Yu
Chen, Che
Xu, Zhe
Li, Wei-Su
Yao, Xue-Quan
Liu, Fu-Kun
Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
title Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
title_full Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
title_fullStr Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
title_full_unstemmed Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
title_short Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
title_sort regional arterial infusion chemotherapy improves the pathological response rate for advanced gastric cancer with short-term neoadjuvant chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664910/
https://www.ncbi.nlm.nih.gov/pubmed/26620627
http://dx.doi.org/10.1038/srep17516
work_keys_str_mv AT wuzhenfeng regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT caoqinhong regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT wuxiaoyu regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT chenche regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT xuzhe regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT liweisu regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT yaoxuequan regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy
AT liufukun regionalarterialinfusionchemotherapyimprovesthepathologicalresponserateforadvancedgastriccancerwithshorttermneoadjuvantchemotherapy